[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.201.14. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
September 2017

Shining (Laser) Light on Traumatic Brain Injury Blood Biomarkers

Author Affiliations
  • 1Boston University School of Medicine, College of Engineering, and Photonics Center, Boston, Massachusetts
  • 2Boston University Alzheimer’s Disease & Chronic Traumatic Encephalopathy Center, Boston, Massachusetts
  • 3Boston Veterans Affairs Healthcare System, Boston, Massachusetts
JAMA Neurol. 2017;74(9):1045-1047. doi:10.1001/jamaneurol.2017.0800

Public awareness of traumatic brain injury (TBI) has grown rapidly in response to recent scientific and media reports on the long-term consequences of concussive and subconcussive head injuries. Three convergent lines of research have sparked far-reaching interest, controversy, and debate. The first has focused on emerging links between sports-related head injuries and later development of chronic traumatic encephalopathy (CTE), a tau protein neurodegenerative disease.1,2 The second focuses on trauma-related brain pathologies in military service members and veterans with blast exposure.3-5 The third concentrated on neuropsychiatric and cognitive sequelae of neurotrauma in both civilian and military groups.6-8

×